Health & Environment
Supreme Court Seeks Wider Price Controls as Medicine Overcharging Claims Hit ₹8,447 Crore
The Hindu1d
THE BRIEF
1
The Supreme Court questioned the Centre on why trade margin caps applied to anti-cancer drugs should not be extended to other medicines and medical products.
2
Outstanding medicine overcharging claims under the Drugs Prices Control Orders stood at ₹8,447.4 crore as of March 31, 2026, according to NPPA records.
3
The National Statistics Office survey from 2025 showed medicine expenditure averaged ₹6,368 in rural areas and ₹6,948 in urban areas per hospitalisation case.